GREENSTREET YVONNE (Chief Executive Officer) received a stock award from ALNYLAM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/22/2026ACC: 0001178670-26-000065
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+107.00
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
107.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+107.00
Price / share
—
Trade value
—
% of position
0.1%
9/19/2026
95.69K→95.80K
Total
Net shares
+107.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/19/2026 | A · Award | +107.00 | — | — | 0.1% | 95.69K | 95.80K |
| Total | +107.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned407.00
Total
407.00 indirect407.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 407.00 | Indirect |
| Total | 407.00 | 407.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported